38 results on '"Jaffray DA"'
Search Results
2. Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
- Author
-
Taremi Mojgan, Hope Andrew, Lindsay Patricia, Dahele Max, Fung Sharon, Purdie Thomas G, Jaffray David, Dawson Laura, and Bezjak Andrea
- Subjects
Stereotactic body radiotherapy ,Radiotherapy toxicity ,Rib fracture ,Nomogram ,Non-small cell lung cancer ,Chest wall pain ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The purpose of this study was to identify clinical and dosimetric factors associated with radiotherapy induced bone injury (RIBI) following stereotactic lung radiotherapy. Methods Inoperable patients with early stage non-small cell lung cancer, treated with SBRT, who received 54 or 60 Gy in 3 fractions, and had a minimum of 6 months follow up were reviewed. Archived treatment plans were retrieved, ribs delineated individually and treatment plans re-computed using heterogeneity correction. Clinical and dosimetric factors were evaluated for their association with rib fracture using logistic regression analysis; a dose-event curve and nomogram were created. Results 46 consecutive patients treated between Oct 2004 and Dec 2008 with median follow-up 25 months (m) (range 6 – 51 m) were eligible. 41 fractured ribs were detected in 17 patients; median time to fracture was 21 m (range 7 – 40 m). The mean maximum point dose in non-fractured ribs (n = 1054) was 10.5 Gy ± 10.2 Gy, this was higher in fractured ribs (n = 41) 48.5 Gy ± 24.3 Gy (p 0.5), and the volume of the rib receiving at least 25 Gy (V25), were significantly associated with RIBI. As D0.5 and V25 were cross-correlated (Spearman correlation coefficient: 0.57, p 0.5 as a representative dose parameter. On multivariate analysis, age (odds ratio: 1.121, 95% CI: 1.04 – 1.21, p = 0.003), female gender (odds ratio: 4.43, 95% CI: 1.68 – 11.68, p = 0.003), and rib D0.5 (odds ratio: 1.0009, 95% CI: 1.0007 – 1.001, p Using D0.5, a dose-event curve was constructed estimating risk of fracture from dose at the median follow up of 25 months after treatment. In our cohort, a 50% risk of rib fracture was associated with a D0.5 of 60 Gy. Conclusions Dosimetric and clinical factors contribute to risk of RIBI and both should be included when modeling risk of toxicity. A nomogram is presented using D0.5, age, and female gender to estimate risk of RIBI following SBRT. This requires validation.
- Published
- 2012
- Full Text
- View/download PDF
3. Acute mental stress detection via ultra-short term HRV analysis
- Author
-
Paolo Melillo, Rossana Castaldo, Leandro Pecchia, Jaffray, DA, Castaldo, Rossana, Melillo, Paolo, and Pecchia, Leandro
- Subjects
medicine.medical_specialty ,Wilcoxon signed-rank test ,Stroop Color Word Test (CWT) ,business.industry ,Cognition ,Acute Mental Stre ,Audiology ,Term (time) ,Sample entropy ,Mental stress ,Detrended fluctuation analysis ,Medicine ,Heart rate variability ,business ,Recurrence plot ,HRV (Heart Rate Variability) ,Clinical psychology - Abstract
Acute mental stress reduces working performanc-es and is one of the first causes of cognitive dysfunctions, car-diovascular disorders and depression. Stress detection via short term (5 minutes) Heart Rate Variability (HRV) has been widely investigated in the last years. Recent improvements in wearable sensing devices and mobile computing raised a new research question: is ultra-short (2 minutes) HRV as effective as the short term one to detect mental stress? This study aimed to answer this research question. Short and ultra-short HRV was compared in 42 healthy subjects (age 25-38 years) under-taking the widely adopted and highly-effective the Stroop Color Word Test (CWT). ECG signals were recorded during rest and stress session using a chest wearable monitoring de-vice, the BioHarness M3 (ZephyrTech, NZ). HRV measures were then extracted and analyzed according to the literature and using validated software tools. Variations between short and ultra-short HRV measures in rest and stress sessions were analysed with the statistical Wilcoxon significance test. The results of the current study suggested that 6 HRV measures are effective in detecting acute mental stress both using short and ultra-short term analysis: Mean RR, Low Frequency power, Sample Entropy, Detrended fluctuation analysis: Short term and Long term fluctuation slope and Mean line length of Recurrence plot analysis.
- Published
- 2015
4. Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights.
- Author
-
Sujit SJ, Aminu M, Karpinets TV, Chen P, Saad MB, Salehjahromi M, Boom JD, Qayati M, George JM, Allen H, Antonoff MB, Hong L, Hu X, Heeke S, Tran HT, Le X, Elamin YY, Altan M, Vokes NI, Sheshadri A, Lin J, Zhang J, Lu Y, Behrens C, Godoy MCB, Wu CC, Chang JY, Chung C, Jaffray DA, Wistuba II, Lee JJ, Vaporciyan AA, Gibbons DL, Heymach J, Zhang J, Cascone T, and Wu J
- Subjects
- Humans, Positron Emission Tomography Computed Tomography methods, Fluorodeoxyglucose F18, Radiopharmaceuticals, Neoplasm Recurrence, Local diagnostic imaging, Neoplasm Recurrence, Local genetics, Neoplasm Recurrence, Local pathology, Positron-Emission Tomography, Tomography, X-Ray Computed, Retrospective Studies, Carcinoma, Non-Small-Cell Lung diagnostic imaging, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung metabolism, Lung Neoplasms diagnostic imaging, Lung Neoplasms genetics, Lung Neoplasms metabolism
- Abstract
While we recognize the prognostic importance of clinicopathological measures and circulating tumor DNA (ctDNA), the independent contribution of quantitative image markers to prognosis in non-small cell lung cancer (NSCLC) remains underexplored. In our multi-institutional study of 394 NSCLC patients, we utilize pre-treatment computed tomography (CT) and
18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) to establish a habitat imaging framework for assessing regional heterogeneity within individual tumors. This framework identifies three PET/CT subtypes, which maintain prognostic value after adjusting for clinicopathologic risk factors including tumor volume. Additionally, these subtypes complement ctDNA in predicting disease recurrence. Radiogenomics analysis unveil the molecular underpinnings of these imaging subtypes, highlighting downregulation in interferon alpha and gamma pathways in the high-risk subtype. In summary, our study demonstrates that these habitat imaging subtypes effectively stratify NSCLC patients based on their risk levels for disease recurrence after initial curative surgery or radiotherapy, providing valuable insights for personalized treatment approaches., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
5. Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy.
- Author
-
Qin K, Wang K, Li S, Hong L, Padmakumar P, Waree R, Hubert SM, Le X, Vokes N, Rai K, Vaporciyan A, Gibbons DL, Heymach JV, Lee JJ, Woodman SE, Chung C, Jaffray DA, Altan M, Lou Y, and Zhang J
- Abstract
Docetaxel +/- ramucirumab remains the standard-of-care therapy for patients with metastatic non-small-cell lung cancer (NSCLC) after progression on platinum doublets and immune checkpoint inhibitors (ICIs). The aim of our study was to investigate whether the cancer gene mutation status was associated with clinical benefits from docetaxel +/- ramucirumab. We also investigated whether platinum/taxane-based regimens offered a better clinical benefit in this patient population. A total of 454 patients were analyzed (docetaxel +/- ramucirumab n=381; platinum/taxane-based regimens n=73). Progression-free survival (PFS) and overall survival (OS) were compared among different subpopulations with different cancer gene mutations and between patients who received docetaxel +/- ramucirumab versus platinum/taxane-based regimens. Among patients who received docetaxel +/- ramucirumab, the top mutated cancer genes included TP53 (n=167), KRAS (n=127), EGFR (n=65), STK11 (n=32), ERBB2 (HER2) (n=26), etc. None of these cancer gene mutations or PD-L1 expression was associated with PFS or OS. Platinum/taxane-based regimens were associated with a significantly longer mQS (13.00 m, 95% Cl: 11.20-14.80 m versus 8.40 m, 95% Cl: 7.12-9.68 m, LogRank P=0.019) than docetaxel +/- ramcirumab. Key prognostic factors including age, histology, and performance status were not different between these two groups. In conclusion, in patients with metastatic NSCLC who have progressed on platinum doublets and ICIs, the clinical benefit from docetaxel +/- ramucirumab is not associated with the cancer gene mutation status. Platinum/taxane-based regimens may offer a superior clinical benefit over docetaxel +/- ramucirumab in this patient population.
- Published
- 2024
- Full Text
- View/download PDF
6. Automated Contouring and Planning in Radiation Therapy: What Is 'Clinically Acceptable'?
- Author
-
Baroudi H, Brock KK, Cao W, Chen X, Chung C, Court LE, El Basha MD, Farhat M, Gay S, Gronberg MP, Gupta AC, Hernandez S, Huang K, Jaffray DA, Lim R, Marquez B, Nealon K, Netherton TJ, Nguyen CM, Reber B, Rhee DJ, Salazar RM, Shanker MD, Sjogreen C, Woodland M, Yang J, Yu C, and Zhao Y
- Abstract
Developers and users of artificial-intelligence-based tools for automatic contouring and treatment planning in radiotherapy are expected to assess clinical acceptability of these tools. However, what is 'clinical acceptability'? Quantitative and qualitative approaches have been used to assess this ill-defined concept, all of which have advantages and disadvantages or limitations. The approach chosen may depend on the goal of the study as well as on available resources. In this paper, we discuss various aspects of 'clinical acceptability' and how they can move us toward a standard for defining clinical acceptability of new autocontouring and planning tools.
- Published
- 2023
- Full Text
- View/download PDF
7. Assessment of intra-fraction motion during frameless image guided Gamma Knife stereotactic radiosurgery.
- Author
-
Li W, Bootsma G, Shultz D, Laperriere N, Millar BA, Cho YB, Jaffray DA, Chung C, and Coolens C
- Abstract
As frameless stereotactic radiosurgery increase in use, the aim of this study was to evaluate intra-fraction motion through cone-beam CT (CBCT) and high-definition motion management (HDMM) systems. Intra-fraction motion measured between localization, repeat localization and post-treatment CBCTs were correlated to intra-faction motion indicated by the HDMM files using the Pearson coefficient (r). A total of 302 plans were reviewed from 263 patients (114 male, 149 female); 216 pairs of localization-repeat localization, and 260 localization-post-treatment CBCTs were analyzed against HDMM logs. We found the magnitude of intra-fraction motion detected by the HDMM system were larger than the corresponding CBCT results., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This work was partially supported through a research grant from Elekta and the Canadian Institutes of Health Research (CIHR); the principal investigators of the grants were Dr. David Jaffray and Dr. Caroline Chung., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
8. Noise-Based Image Harmonization Significantly Increases Repeatability and Reproducibility of Radiomics Features in PET Images: A Phantom Study.
- Author
-
Keller H, Shek T, Driscoll B, Xu Y, Nghiem B, Nehmeh S, Grkovski M, Schmidtlein CR, Budzevich M, Balagurunathan Y, Sunderland JJ, Beichel RR, Uribe C, Lee TY, Li F, Jaffray DA, and Yeung I
- Subjects
- Phantoms, Imaging, Reproducibility of Results, Positron-Emission Tomography methods
- Abstract
For multicenter clinical studies, characterizing the robustness of image-derived radiomics features is essential. Features calculated on PET images have been shown to be very sensitive to image noise. The purpose of this work was to investigate the efficacy of a relatively simple harmonization strategy on feature robustness and agreement. A purpose-built texture pattern phantom was scanned on 10 different PET scanners in 7 institutions with various different image acquisition and reconstruction protocols. An image harmonization technique based on equalizing a contrast-to-noise ratio was employed to generate a "harmonized" alongside a "standard" dataset for a reproducibility study. In addition, a repeatability study was performed with images from a single PET scanner of variable image noise, varying the binning time of the reconstruction. Feature agreement was measured using the intraclass correlation coefficient (ICC). In the repeatability study, 81/93 features had a lower ICC on the images with the highest image noise as compared to the images with the lowest image noise. Using the harmonized dataset significantly improved the feature agreement for five of the six investigated feature classes over the standard dataset. For three feature classes, high feature agreement corresponded with higher sensitivity to the different patterns, suggesting a way to select suitable features for predictive models.
- Published
- 2022
- Full Text
- View/download PDF
9. Cancer Needs a Robust "Metadata Supply Chain" to Realize the Promise of Artificial Intelligence.
- Author
-
Chung C and Jaffray DA
- Subjects
- Humans, Artificial Intelligence, Metadata statistics & numerical data, Neoplasms diagnosis, Neoplasms therapy
- Abstract
Profound advances in computational methods, including artificial intelligence (AI), present the opportunity to use the exponentially growing volume and complexity of available cancer measurements toward data-driven personalized care. While exciting, this opportunity has highlighted the disconnect between the promise of compute and the supply of high-quality data. The current paradigm of ad-hoc aggregation and curation of data needs to be replaced with a "metadata supply chain" that provides robust data in context with known provenance, that is, lineage and comprehensive data governance that will allow the promise of AI technology to be realized to its full potential in clinical practice., (©2021 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
10. Flat-panel conebeam CT in the clinic: history and current state.
- Author
-
Fahrig R, Jaffray DA, Sechopoulos I, and Webster Stayman J
- Abstract
Research into conebeam CT concepts began as soon as the first clinical single-slice CT scanner was conceived. Early implementations of conebeam CT in the 1980s focused on high-contrast applications where concurrent high resolution ( < 200 μ m ), for visualization of small contrast-filled vessels, bones, or teeth, was an imaging requirement that could not be met by the contemporaneous CT scanners. However, the use of nonlinear imagers, e.g., x-ray image intensifiers, limited the clinical utility of the earliest diagnostic conebeam CT systems. The development of consumer-electronics large-area displays provided a technical foundation that was leveraged in the 1990s to first produce large-area digital x-ray detectors for use in radiography and then compact flat panels suitable for high-resolution and high-frame-rate conebeam CT. In this review, we show the concurrent evolution of digital flat panel (DFP) technology and clinical conebeam CT. We give a brief summary of conebeam CT reconstruction, followed by a brief review of the correction approaches for DFP-specific artifacts. The historical development and current status of flat-panel conebeam CT in four clinical areas-breast, fixed C-arm, image-guided radiation therapy, and extremity/head-is presented. Advances in DFP technology over the past two decades have led to improved visualization of high-contrast, high-resolution clinical tasks, and image quality now approaches the soft-tissue contrast resolution that is the standard in clinical CT. Future technical developments in DFPs will enable an even broader range of clinical applications; research in the arena of flat-panel CT shows no signs of slowing down., (© 2021 The Authors.)
- Published
- 2021
- Full Text
- View/download PDF
11. Evaluating an Image-Guided Operating Room with Cone Beam CT for Skull Base Surgery.
- Author
-
Muhanna N, Douglas CM, Daly MJ, Chan HHL, Weersink R, Townson J, Monteiro E, Yu E, Weimer E, Kucharczyk W, Jaffray DA, Irish JC, and de Almeida JR
- Abstract
Importance Skull base surgery requires precise preoperative assessment and intraoperative management of the patient. Surgical navigation is routinely used for complex skull base cases; however, the image guidance is commonly based on preoperative scans alone. Objective The primary objective of this study was to assess the image quality of intraoperative cone-beam computed tomography (CBCT) within anatomical landmarks used in sinus and skull base surgery. The secondary objective was to assess the registration error of a surgical navigation system based on intraoperative CBCT. Design Present study is a retrospective case series of image quality after intraoperative cone beam CT. Setting The study was conducted at Toronto General Hospital and Princess Margaret Cancer Centre, University Health Network, Toronto. Participants A total of 46 intraoperative scans (34 patients, 21 skull base, 13 head and neck) were studied. Main Outcome and Measures Thirty anatomical landmarks (vascular, soft tissue, and bony) within the sinuses and anterior skull base were evaluated for general image quality characteristics: (1) bony detail visualization; (2) soft-tissue visualization; (3) vascular visualization; and (4) freedom from artifacts (e.g., metal). Levels of intravenous (IV) contrast enhancement were quantified in Hounsfield's units (HU). Standard paired-point registration between imaging and tracker coordinates was performed using 6 to 8 skin fiducial markers and the corresponding fiducial registration error (FRE) was measured. Results Median score for bony detail on CBCT was 5, remaining at 5 after administration of IV contrast. Median soft-tissue score was 2 for both pre- and postcontrast. Median vascular score was 1 precontrast and 3 postcontrast. Median score for artifacts on CBCT were 2 for both pre-and postcontrast, and metal objects were noted to be the most significant source of artifact. Intraoperative CBCT allowed preresection images and immediate postresection images to be available to the skull base surgeon. There was a significant improvement in mean (standard deviation [SD]) CT intensity in the left carotid artery postcontrast 334 HU (67 HU) ( p < 10
-10 ). The mean FRE was 1.8 mm (0.45 mm). Conclusion Intraoperative CBCT in complex skull base procedures provides high-resolution bony detail allowing immediate assessment of complex resections. The use of IV contrast with CBCT improves the visualization of vasculature. Image-guidance based on CBCT yields registration errors consistent with standard techniques., Competing Interests: Conflict of Interest None declared., (Thieme. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
12. In situ tissue pathology from spatially encoded mass spectrometry classifiers visualized in real time through augmented reality.
- Author
-
Woolman M, Qiu J, Kuzan-Fischer CM, Ferry I, Dara D, Katz L, Daud F, Wu M, Ventura M, Bernards N, Chan H, Fricke I, Zaidi M, Wouters BG, Rutka JT, Das S, Irish J, Weersink R, Ginsberg HJ, Jaffray DA, and Zarrine-Afsar A
- Abstract
Integration between a hand-held mass spectrometry desorption probe based on picosecond infrared laser technology (PIRL-MS) and an optical surgical tracking system demonstrates in situ tissue pathology from point-sampled mass spectrometry data. Spatially encoded pathology classifications are displayed at the site of laser sampling as color-coded pixels in an augmented reality video feed of the surgical field of view. This is enabled by two-way communication between surgical navigation and mass spectrometry data analysis platforms through a custom-built interface. Performance of the system was evaluated using murine models of human cancers sampled in situ in the presence of body fluids with a technical pixel error of 1.0 ± 0.2 mm, suggesting a 84% or 92% (excluding one outlier) cancer type classification rate across different molecular models that distinguish cell-lines of each class of breast, brain, head and neck murine models. Further, through end-point immunohistochemical staining for DNA damage, cell death and neuronal viability, spatially encoded PIRL-MS sampling is shown to produce classifiable mass spectral data from living murine brain tissue, with levels of neuronal damage that are comparable to those induced by a surgical scalpel. This highlights the potential of spatially encoded PIRL-MS analysis for in vivo use during neurosurgical applications of cancer type determination or point-sampling in vivo tissue during tumor bed examination to assess cancer removal. The interface developed herein for the analysis and the display of spatially encoded PIRL-MS data can be adapted to other hand-held mass spectrometry analysis probes currently available., Competing Interests: There are no conflicts to declare., (This journal is © The Royal Society of Chemistry.)
- Published
- 2020
- Full Text
- View/download PDF
13. [ 18 F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.
- Author
-
Glicksman RM, Metser U, Valliant J, Chung PW, Fleshner NE, Bristow RG, Green D, Finelli A, Hamilton R, Stanescu T, Hussey D, Catton C, Gospodarowicz M, Warde P, Bayley A, Breen S, Vines D, Jaffray DA, and Berlin A
- Subjects
- Canada, Clinical Trials, Phase II as Topic, Humans, Male, Neoplasm Recurrence, Local diagnostic imaging, Magnetic Resonance Imaging, Positron Emission Tomography Computed Tomography, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms radiotherapy, Prostatic Neoplasms surgery
- Abstract
Introduction: The oligometastatic (OM) disease hypothesis of an intermediate metastatic state with limited distant disease deposits amenable for curative therapies remains debatable. Over a third of prostate cancer (PCa) patients treated with radical prostatectomy and postoperative radiotherapy experience disease recurrence; these patients are considered incurable by current standards. Often the recurrence cannot be localised by conventional imaging (CT and bone scan). Combined anatomical imaging with CT and/or MR with positron emission tomography (PET) using a novel second-generation prostate-specific membrane antigen (PSMA) probe, [
18 F]DCFPyL, is a promising imaging modality to unveil disease deposits in these patients. A new and earlier molecularly defined oligorecurrent (OR) state may be amenable to focal-targeted ablative curative-intent therapies, such as stereotactic ablative radiotherapy (SABR) or surgery, thereby significantly delaying or completely avoiding the need for palliative therapies in men with recurrent PCa after maximal local treatments., Methods and Analysis: This ongoing single-institution phase II study will enrol up to 75 patients total, to include up to 37 patients with response-evaluable disease, who have rising prostate-specific antigen (range 0.4-3.0 ng/mL) following maximal local therapies with no evidence of disease on conventional imaging. These patients will undergo [18 F]DCFPyL PET-MR/CT imaging to detect disease deposits, which will then be treated with SABR or surgery. The primary endpoints are performance of [18 F]DCFPyL PET-MR/CT, and treatment response rates following SABR or surgery. Demographics and disease characteristics will be summarised and analysed descriptively. Response rates will be described with waterfall plots and proportions., Ethics and Dissemination: Ethics approval was obtained from the institutional Research Ethics Board. All patients will provide written informed consent. [18 F]DCFPyL has approval from Health Canada. The results of the study will be disseminated by the principal investigator. Patients will not be identifiable as individuals in any publication or presentation of this study., Trial Registration Numbers: NCT03160794., Competing Interests: Competing interests: UM declares a competing interest with Point Biopharm Inc. as a consultant., (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2020
- Full Text
- View/download PDF
14. Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy.
- Author
-
Taylor E, Zhou J, Lindsay P, Foltz W, Cheung M, Siddiqui I, Hosni A, Amir AE, Kim J, Hill RP, Jaffray DA, and Hedley DW
- Subjects
- Adenocarcinoma metabolism, Adenocarcinoma radiotherapy, Animals, Humans, Hypoxia metabolism, Hypoxia radiotherapy, Mice, Positron-Emission Tomography methods, Radiopharmaceuticals therapeutic use, Radiosurgery methods, Pancreatic Neoplasms, Oxygen metabolism, Pancreatic Neoplasms metabolism, Pancreatic Neoplasms radiotherapy
- Abstract
Hypoxia, the state of low oxygenation that often arises in solid tumours due to their high metabolism and irregular vasculature, is a major contributor to the resistance of tumours to radiation therapy (RT) and other treatments. Conventional RT extends treatment over several weeks or more, and nominally allows time for oxygen levels to increase ("reoxygenation") as cancer cells are killed by RT, mitigating the impact of hypoxia. Recent advances in RT have led to an increase in the use stereotactic body radiotherapy (SBRT), which delivers high doses in five or fewer fractions. For cancers such as pancreatic adenocarcinoma for which hypoxia varies significantly between patients, SBRT might not be optimal, depending on the extent to which reoxygenation occurs during its short duration. We used fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole positron-emission tomography (FAZA-PET) imaging to quantify hypoxia before and after 5-fraction SBRT delivered to patient-derived pancreatic cancer xenografts orthotopically implanted in mice. An imaging technique using only the pre-treatment FAZA-PET scan and repeat dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) scans throughout treatment was able to predict the change in hypoxia. Our results support the further testing of this technique for imaging of reoxygenation in the clinic.
- Published
- 2020
- Full Text
- View/download PDF
15. Intraoperative Near-Infrared Fluorescence-Guided Peripheral Lung Tumor Localization in Rabbit Models.
- Author
-
Wada H, Zheng J, Gregor A, Hirohashi K, Hu HP, Patel P, Ujiie H, Kato T, Anayama T, Jaffray DA, and Yasufuku K
- Subjects
- Animals, Coloring Agents administration & dosage, Coloring Agents pharmacokinetics, Indocyanine Green pharmacokinetics, Injections, Intralesional, Intraoperative Period, Liposomes administration & dosage, Liposomes pharmacokinetics, Lung Neoplasms surgery, Rabbits, Reproducibility of Results, Indocyanine Green administration & dosage, Lung Neoplasms diagnosis, Neoplasms, Experimental, Spectroscopy, Near-Infrared methods, Surgery, Computer-Assisted methods
- Abstract
Background: A novel liposomal nanoparticle, CF800, that co-encapsulates indocyanine green for near-infrared (NIR) imaging and iohexol for computed tomography (CT) imaging has shown preferential tumor accumulation after intravenous injection by the enhanced permeability and retention effect. We hypothesized that CF800-enhanced NIR imaging would facilitate intraoperative localization of small lung nodules., Methods: A rabbit VX2 lung tumor model was implemented. CF800 was injected intravenously, followed by sequential CT acquisitions to track the biodistribution of CF800. Eleven rabbits were used for NIR fluorescence evaluation after thoracotomy at time points until 7 days after injection by using a NIR fluorescence thoracoscope in vivo. Organs of interests were removed for ex vivo analysis by using NIR imaging. Tumor-to-background (inflated lung) ratio was calculated and compared among the time points., Results: Both CT and NIR imaging indicated enhanced accumulation of CF800 within the VX2 tumor. NIR image analysis revealed the highest tumor-to-background ratio on days 4 and 5. High background at day 2 and low tumor signal at day 7 prevented distinct demarcation. Metastatic pulmonary small nodules (less than 2 mm in diameter) were successfully visualized by NIR imaging on day 4. However, NIR signal penetration was limited, resulting in localization failure for the few tumors deep (>0 mm) to the lung surface., Conclusions: NIR image-guided localization of small lung nodules appears to be feasible under certain conditions. However, further refinement will be required to increase tumor signal intensity and to reduce background signal from normal lung parenchyma, which is at least in part a consequence of persistent CF800 in the vasculature., (Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
16. Altered brain morphology after focal radiation reveals impact of off-target effects: implications for white matter development and neurogenesis.
- Author
-
Beera KG, Li YQ, Dazai J, Stewart J, Egan S, Ahmed M, Wong CS, Jaffray DA, and Nieman BJ
- Subjects
- Animals, Brain radiation effects, Magnetic Resonance Imaging, Mice, Myelin Sheath radiation effects, White Matter radiation effects, Brain pathology, Cranial Irradiation adverse effects, Myelin Sheath pathology, Neurogenesis radiation effects, White Matter pathology
- Abstract
Background: Children with brain tumors treated with cranial radiation therapy (RT) often exhibit cognitive late effects, commonly associated with reduced white matter (WM) volume and decreased neurogenesis. The impact of radiation damage in particular regions or tissues on brain development as a whole has not been elucidated., Methods: We delivered whole-brain or focal radiation (8 Gy single dose) to infant mice. Focal treatments targeted white matter (anterior commissure), neuronal (olfactory bulbs), or neurogenic (subventricular zone) regions. High-resolution ex vivo MRI was used to assess radiation-induced volume differences. Immunohistochemistry for myelin basic protein and doublecortin was performed to assess associated cellular changes within white matter and related to neurogenesis, respectively., Results: Both whole-brain and focal RT in infancy resulted in volume deficits in young adulthood, with whole-brain RT resulting in the largest deficits. RT of the anterior commissure, surprisingly, showed no impact on its volume or on brain development as a whole. In contrast, RT of the olfactory bulbs resulted in off-target volume reduction in the anterior commissure and decreased subventricular zone neurogenesis. RT of the subventricular zone likewise produced volume deficits in both the olfactory bulbs and the anterior commissure. Similar off-target effects were found in the corpus callosum and parietal cortex., Conclusions: Our results demonstrate that radiation damage locally can have important off-target consequences for brain development. These data suggest that WM may be less radiosensitive than volume change alone would indicate and have implications for region-sparing radiation treatments aimed at reducing cognitive late effects.
- Published
- 2018
- Full Text
- View/download PDF
17. Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
- Author
-
Fricke IB, De Souza R, Costa Ayub L, Francia G, Kerbel R, Jaffray DA, and Zheng J
- Subjects
- Animals, Axilla pathology, Cell Line, Tumor, Contrast Media pharmacokinetics, Female, Gene Expression, Humans, Liver Neoplasms genetics, Liver Neoplasms secondary, Luminescent Measurements instrumentation, Luminescent Measurements methods, Lung Neoplasms genetics, Lung Neoplasms secondary, Mice, Mice, SCID, Multidetector Computed Tomography instrumentation, Multidetector Computed Tomography methods, Neoplasm Transplantation, Optical Imaging instrumentation, Optical Imaging methods, Positron-Emission Tomography instrumentation, Positron-Emission Tomography methods, Receptor, ErbB-2 metabolism, Transplantation, Heterologous, Triple Negative Breast Neoplasms genetics, Triple Negative Breast Neoplasms pathology, Axilla diagnostic imaging, Liver Neoplasms diagnostic imaging, Lung Neoplasms diagnostic imaging, Receptor, ErbB-2 genetics, Triple Negative Breast Neoplasms diagnostic imaging
- Abstract
Background: Preclinical breast cancer models recapitulating the clinical course of metastatic disease are crucial for drug development. Highly metastatic cell lines forming spontaneous metastasis following orthotopic implantation were previously developed and characterized regarding their biological and histological characteristics. This study aimed to non-invasively and longitudinally characterize the spatiotemporal pattern of metastasis formation and progression in the MDA-MB-231-derived triple negative LM2-4 and HER2+ LM2-4H2N cell lines, using bioluminescence imaging (BLI), contrast enhanced computed tomography (CT), fluorescence imaging, and 2-deoxy-2-[fluorine-18]fluoro-D-glucose positron emission tomography ([18F]FDG-PET)., Material and Methods: LM2-4, LM2-4H2N, and MDA-MB-231 tumors were established in the right inguinal mammary fat pad (MFP) of female SCID mice and resected 14-16 days later. Metastasis formation was monitored using BLI. Metabolic activity of primary and metastatic lesions in mice bearing LM2-4 or LM2-4H2N was assessed by [18F]FDG-PET. Metastatic burden at study endpoint was assessed by CT and fluorescence imaging following intravenous dual-modality liposome agent administration., Results: Comparable temporal metastasis patterns were observed using BLI for the highly metastatic cell lines LM2-4 and LM2-4H2N, while metastasis formed about 10 days later for MDA-MB-231. 21 days post primary tumor resection, metastases were detected in 86% of LM2-4, 69% of LM2-4H2N, and 60% of MDA-MB-231 inoculated mice, predominantly in the axillary region, contralateral MFP, and liver/lung. LM2-4 and LM2-4H2N tumors displayed high metabolism based on [18F]FDG-PET uptake. Lung metastases were detected as the [18F]FDG-PET uptake increased significantly between pre- and post-metastasis scan. Using a liposomal dual-modality agent, CT and fluorescence confirmed BLI detected lesions and identified additional metastatic nodules in the intraperitoneal cavity and lung., Conclusions: The combination of complementary anatomical and functional imaging techniques can provide high sensitivity characterization of metastatic disease spread, progression and overall disease burden. The described models and imaging toolset can be implemented as an effective means for quantitative treatment response evaluation in metastatic breast cancer.
- Published
- 2018
- Full Text
- View/download PDF
18. Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.
- Author
-
Haynes J, McKee TD, Haller A, Wang Y, Leung C, Gendoo DMA, Lima-Fernandes E, Kreso A, Wolman R, Szentgyorgyi E, Vines DC, Haibe-Kains B, Wouters BG, Metser U, Jaffray DA, Smith M, and O'Brien CA
- Subjects
- Animals, Biomarkers, Caspases metabolism, Cell Hypoxia drug effects, Cell Line, Tumor, Cell Proliferation drug effects, Chemoradiotherapy, Colorectal Neoplasms drug therapy, Colorectal Neoplasms pathology, Colorectal Neoplasms radiotherapy, Disease Models, Animal, Drug Evaluation, Preclinical, Drug Synergism, Female, Humans, Male, Mice, Phenotype, Positron-Emission Tomography, Standard of Care, Wnt Signaling Pathway, Xenograft Model Antitumor Assays, Colorectal Neoplasms metabolism, Hypoxia metabolism, Neoplastic Stem Cells drug effects, Neoplastic Stem Cells metabolism, Nitroimidazoles administration & dosage, Phosphoramide Mustards administration & dosage, Prodrugs administration & dosage
- Abstract
Purpose: Cancer-initiating cells (C-IC) have been described in multiple cancer types, including colorectal cancer. C-ICs are defined by their capacity to self-renew, thereby driving tumor growth. C-ICs were initially thought to be static entities; however, recent studies have determined these cells to be dynamic and influenced by microenvironmental cues such as hypoxia. If hypoxia drives the formation of C-ICs, then therapeutic targeting of hypoxia could represent a novel means to target C-ICs. Experimental Design: Patient-derived colorectal cancer xenografts were treated with evofosfamide, a hypoxia-activated prodrug (HAP), in combination with 5-fluorouracil (5-FU) or chemoradiotherapy (5-FU and radiation; CRT). Treatment groups included both concurrent and sequential dosing regimens. Effects on the colorectal cancer-initiating cell (CC-IC) fraction were assessed by serial passage in vivo limiting dilution assays. FAZA-PET imaging was utilized as a noninvasive method to assess intratumoral hypoxia. Results: Hypoxia was sufficient to drive the formation of CC-ICs and colorectal cancer cells surviving conventional therapy were more hypoxic and C-IC-like. Using a novel approach to combination therapy, we show that sequential treatment with 5-FU or CRT followed by evofosfamide not only inhibits tumor growth of xenografts compared with 5-FU or CRT alone, but also significantly decreases the CC-IC fraction. Furthermore, noninvasive FAZA-PET hypoxia imaging was predictive of a tumor's response to evofosfamide. Conclusions: Our data demonstrate a novel means to target the CC-IC fraction by adding a HAP sequentially after conventional adjuvant therapy, as well as the use of FAZA-PET as a biomarker for hypoxia to identify tumors that will benefit most from this approach. Clin Cancer Res; 24(9); 2116-27. ©2018 AACR ., (©2018 American Association for Cancer Research.)
- Published
- 2018
- Full Text
- View/download PDF
19. Impact of tissue transport on PET hypoxia quantification in pancreatic tumours.
- Author
-
Taylor E, Gottwald J, Yeung I, Keller H, Milosevic M, Dhani NC, Siddiqui I, Hedley DW, and Jaffray DA
- Abstract
Background: The clinical impact of hypoxia in solid tumours is indisputable and yet questions about the sensitivity of hypoxia-PET imaging have impeded its uptake into routine clinical practice. Notably, the binding rate of hypoxia-sensitive PET tracers is slow, comparable to the rate of diffusive equilibration in some tissue types, including mucinous and necrotic tissue. This means that tracer uptake on the scale of a PET imaging voxel-large enough to include such tissue and hypoxic cells-can be as much determined by tissue transport properties as it is by hypoxia. Dynamic PET imaging of 20 patients with pancreatic ductal adenocarcinoma was used to assess the impact of transport on surrogate metrics of hypoxia: the tumour-to-blood ratio [TBR(t)] at time t post-tracer injection and the trapping rate k
3 inferred from a two-tissue compartment model. Transport quantities obtained from this model included the vascular influx and efflux rate coefficients, k1 and k2 , and the distribution volume vd ≡k1 /(k2 +k3 )., Results: Correlations between voxel- and whole tumour-scale k3 and TBR values were weak to modest: the population average of the Pearson correlation coefficients (r) between voxel-scale k3 and TBR (1 h) [TBR(2 h)] values was 0.10 [0.01] in the 20 patients, while the correlation between tumour-scale k3 and TBR(2 h) values was 0.58. Using Patlak's formula to correct uptake for the distribution volume, correlations became strong (r=0.80[0.52] and r=0.93, respectively). The distribution volume was substantially below unity for a large fraction of tumours studied, with vd ranging from 0.68 to 1 (population average, 0.85). Surprisingly, k3 values were strongly correlated with vd in all patients. A model was proposed to explain this in which k3 is a combination of the hypoxia-sensitive tracer binding rate kb and the rate keq of equilibration in slow-equilibrating regions occupying a volume fraction 1-vd of the imaged tissue. This model was used to calculate the proposed hypoxia surrogate marker kb ., Conclusions: Hypoxia-sensitive PET tracers are slow to reach diffusive equilibrium in a substantial fraction of pancreatic tumours, confounding quantification of hypoxia using both static (TBR) and dynamic (k3 ) PET imaging. TBR is reduced by distribution volume effects and k3 is enhanced by slow equilibration. We proposed a novel model to quantify tissue transport properties and hypoxia-sensitive tracer binding in order to improve the sensitivity of hypoxia-PET imaging.- Published
- 2017
- Full Text
- View/download PDF
20. Editorial: Radiomics: The New World or Another Road to El Dorado?
- Author
-
Welch ML and Jaffray DA
- Subjects
- Humans, Diagnosis, Computer-Assisted methods, Image Interpretation, Computer-Assisted methods, Neoplasms diagnosis, Radiography methods
- Published
- 2017
- Full Text
- View/download PDF
21. In Vitro and In Vivo Studies of a New Class of Anticancer Molecules for Targeted Radiotherapy of Cancer.
- Author
-
Wang CR, Mahmood J, Zhang QR, Vedadi A, Warrington J, Ou N, Bristow RG, Jaffray DA, and Lu QB
- Subjects
- Animals, Apoptosis drug effects, Apoptosis genetics, Apoptosis radiation effects, Cell Line, Tumor, Combined Modality Therapy, DNA Breaks, Double-Stranded drug effects, DNA Breaks, Double-Stranded radiation effects, Disease Models, Animal, Female, Fibroblasts drug effects, Fibroblasts metabolism, Humans, Mice, Molecular Targeted Therapy, Neoplasms diagnosis, Neoplasms drug therapy, Neoplasms radiotherapy, Radiotherapy, Tumor Burden drug effects, Tumor Burden radiation effects, X-Rays, Xenograft Model Antitumor Assays, Antineoplastic Agents pharmacology, Drug Discovery, Radiation-Sensitizing Agents pharmacology
- Abstract
There is a compelling need to develop anticancer therapies that target cancer cells and tissues. Arising from innovative femtomedicine studies, a new class of non-platinum-based halogenated molecules (called FMD molecules) that selectively kill cancer cells and protect normal cells in treatments of multiple cancers has been discovered. This article reports the first observation of the radiosensitizing effects of such compounds in combination with ionizing radiation for targeted radiotherapy of a variety of cancers. We present in vitro and in vivo studies focused on combination with radiotherapy of cervical, ovarian, head and neck, and lung cancers. Our results demonstrate that treatments of various cancer cells in vitro and in vivo mouse xenograft models with such compounds led to enhanced efficiencies in radiotherapy, while the compounds themselves induced no or little radiotoxicity toward normal cells or tissues. These compounds are therefore effective radiosensitizers that can be translated into clinical trials for targeted radiotherapy of multiple types of cancer. This study also shows the potential of femtomedicine to bring breakthroughs in understanding fundamental biologic processes and to accelerate the discovery of novel drugs for effective treatment or prevention of a variety of cancers. Mol Cancer Ther; 15(4); 640-50. ©2016 AACR., (©2016 American Association for Cancer Research.)
- Published
- 2016
- Full Text
- View/download PDF
22. Wide-field tissue polarimetry allows efficient localized mass spectrometry imaging of biological tissues.
- Author
-
Tata A, Gribble A, Ventura M, Ganguly M, Bluemke E, Ginsberg HJ, Jaffray DA, Ifa DR, Vitkin A, and Zarrine-Afsar A
- Abstract
While mass spectrometers can detect chemical signatures within milliseconds of data acquisition time, the non-targeted nature of mass spectrometry imaging (MSI) necessitates probing the entire surface of the sample to reveal molecular composition even if the information is only sought from a sample subsection. This leads to long analysis times. Here, we used polarimetry to identify, within a biological tissue, areas of polarimetric heterogeneity indicative of cancer. We were then able to target our MS analysis using polarimetry results to either the cancer region itself or to the cancer margin. A tandem of polarimetry and Desorption Electrospray Ionization Mass Spectrometry Imaging (DESI-MSI) enables fast (10 fold compared to non-targeted imaging), and accurate pathology assessment (cancer typification in less than 2 minutes compared to 30 minutes for histopathology) of ex vivo tissue slices, without additional sample preparation. This workflow reduces the overall analysis time of MSI as a research tool.
- Published
- 2016
- Full Text
- View/download PDF
23. Direct Lymph Node Vaccination of Lentivector/Prostate-Specific Antigen is Safe and Generates Tissue-Specific Responses in Rhesus Macaques.
- Author
-
Au BC, Lee CJ, Lopez-Perez O, Foltz W, Felizardo TC, Wang JCM, Huang J, Fan X, Madden M, Goldstein A, Jaffray DA, Moloo B, McCart JA, and Medin JA
- Abstract
Anti-cancer immunotherapy is emerging from a nadir and demonstrating tangible benefits to patients. A variety of approaches are now employed. We are invoking antigen (Ag)-specific responses through direct injections of recombinant lentivectors (LVs) that encode sequences for tumor-associated antigens into multiple lymph nodes to optimize immune presentation/stimulation. Here we first demonstrate the effectiveness and antigen-specificity of this approach in mice challenged with prostate-specific antigen (PSA)-expressing tumor cells. Next we tested the safety and efficacy of this approach in two cohorts of rhesus macaques as a prelude to a clinical trial application. Our vector encodes the cDNA for rhesus macaque PSA and a rhesus macaque cell surface marker to facilitate vector titering and tracking. We utilized two independent injection schemas demarcated by the timing of LV administration. In both cohorts we observed marked tissue-specific responses as measured by clinical evaluations and magnetic resonance imaging of the prostate gland. Tissue-specific responses were sustained for up to six months-the end-point of the study. Control animals immunized against an irrelevant Ag were unaffected. We did not observe vector spread in test or control animals or perturbations of systemic immune parameters. This approach thus offers an "off-the-shelf" anti-cancer vaccine that could be made at large scale and injected into patients-even on an out-patient basis.
- Published
- 2016
- Full Text
- View/download PDF
24. Longitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity.
- Author
-
Zheng J, Klinz SG, De Souza R, Fitzgerald J, and Jaffray DA
- Abstract
Background: Non-invasive measurement of tumor hypoxia has demonstrated potential for the evaluation of disease progression, as well as prediction and assessment of treatment outcome. [(18)F]fluoroazomycin arabinoside (FAZA) positron emission tomography (PET) has been identified as a robust method for quantification of hypoxia both preclinically and clinically. The goal of this investigation was to evaluate the feasibility and value of repeated FAZA-PET imaging to quantify hypoxia in tumors that received multi-dose chemotherapy., Methods: FAZA-PET imaging was conducted over a 21-day period in a mouse xenograft model of HT-29 human colorectal carcinoma, following multi-dose chemotherapy treatment with irinotecan (CPT-11) or nanoliposomal irinotecan (nal-IRI, MM-398)., Results: Tumors treated with 10 mg/kg nal-IRI maintained significantly lower levels of hypoxia and smaller hypoxic fractions compared to tumors that received 50 mg/kg CPT-11. Specifically, differences in FAZA uptake were detectable 9 days before any significant differences in tumor volume were observed between the treatment groups., Conclusions: These findings highlight the potential use of FAZA-PET as an early marker of treatment response following multi-dose chemotherapy.
- Published
- 2015
- Full Text
- View/download PDF
25. Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302).
- Author
-
Geretti E, Leonard SC, Dumont N, Lee H, Zheng J, De Souza R, Gaddy DF, Espelin CW, Jaffray DA, Moyo V, Nielsen UB, Wickham TJ, and Hendriks BS
- Subjects
- Animals, Antibiotics, Antineoplastic administration & dosage, Apoptosis drug effects, Breast Neoplasms diagnosis, Breast Neoplasms drug therapy, Cell Line, Tumor, Cyclophosphamide administration & dosage, Disease Models, Animal, Doxorubicin administration & dosage, Drug Synergism, Female, Humans, Ifosfamide administration & dosage, Ifosfamide pharmacology, Mice, Polyethylene Glycols administration & dosage, Positron-Emission Tomography, Tomography, X-Ray Computed, Tumor Microenvironment, Xenograft Model Antitumor Assays, Antibiotics, Antineoplastic pharmacology, Breast Neoplasms metabolism, Cyclophosphamide pharmacology, Doxorubicin analogs & derivatives, Receptor, ErbB-2 antagonists & inhibitors
- Abstract
Given the bulky nature of nanotherapeutics relative to small molecules, it is hypothesized that effective tumor delivery and penetration are critical barriers to their clinical activity. HER2-targeted PEGylated liposomal doxorubicin (MM-302, HER2-tPLD) is an antibody-liposomal drug conjugate designed to deliver doxorubicin to HER2-overexpressing cancer cells while limiting uptake into nontarget cells. In this work, we demonstrate that the administration and appropriate dose sequencing of cyclophosphamide can improve subsequent MM-302 delivery and enhance antitumor activity in preclinical models without negatively affecting nontarget tissues, such as the heart and skin. We demonstrate that this effect is critically dependent on the timing of cyclophosphamide administration. Furthermore, the effect was found to be unique to cyclophosphamide and related analogues, and not shared by other agents, such as taxanes or eribulin, under the conditions examined. Analysis of the cyclophosphamide-treated tumors suggests that the mechanism for improved MM-302 delivery involves the induction of tumor cell apoptosis, reduction of overall tumor cell density, substantial lowering of interstitial fluid pressure, and increasing vascular perfusion. The novel dosing strategy for cyclophosphamide described herein is readily translatable to standard clinical regimens, represents a potentially significant advance in addressing the drug delivery challenge, and may have broad applicability for nanomedicines. This work formed the basis for clinical evaluation of cyclophosphamide for improving liposome deposition as part of an ongoing phase I clinical trial of MM-302 in HER2-positive metastatic breast cancer., (©2015 American Association for Cancer Research.)
- Published
- 2015
- Full Text
- View/download PDF
26. Minimally invasive electro-magnetic navigational bronchoscopy-integrated near-infrared-guided sentinel lymph node mapping in the porcine lung.
- Author
-
Wada H, Hirohashi K, Anayama T, Nakajima T, Kato T, Chan HH, Qiu J, Daly M, Weersink R, Jaffray DA, Irish JC, Waddell TK, Keshavjee S, Yoshino I, and Yasufuku K
- Subjects
- Animals, Bronchi pathology, Fluorescence, Indocyanine Green, Injections, Lymph Nodes pathology, Pleura pathology, Time Factors, Bronchoscopy methods, Electromagnetic Fields, Lung pathology, Sentinel Lymph Node Biopsy methods, Spectroscopy, Near-Infrared methods
- Abstract
Background: The use of near-infrared (NIR) fluorescence imaging with indocyanine green (ICG) for sentinel lymph node (SN) mapping has been investigated in lung cancer; however, this has not been fully adapted for minimally invasive surgery (MIS). The aim of our study was to develop a minimally invasive SN mapping integrating pre-operative electro-magnetic navigational bronchoscopy (ENB)-guided transbronchial ICG injection and intraoperative NIR thoracoscopic imaging., Methods: A NIR thoracoscope was used to visualize ICG fluorescence. ICG solutions in a 96-well plate and ex vivo porcine lungs were examined to optimize ICG concentrations and injection volumes. Transbronchial ICG injection (n=4) was assessed in comparison to a traditional transpleural approach (n=3), where after thoracotomy an ICG solution (100 μL at 100 μg/mL) was injected into the porcine right upper lobe for SN identification. For further translation into clinical use, transbronchial ICG injection prior to thoracotomy followed by NIR thoracoscopic imaging was validated (n=3). ENB was used for accurate targeting in two pigs with a pseudo-tumor., Results: The ICG fluorescence at 10 μg/mL was the brightest among various concentrations, unchanged by the distance between the thoracoscope and ICG solutions. Injected ICG of no more than 500μ L showed a localized fluorescence area. All 7 pigs showed a bright paratracheal lymph node within 15 minutes post-injection, with persistent fluorescence for 60 minutes. The antecedent transbronchial ICG injection succeeded in SN identification in all 3 cases at the first thoracoscopic inspection within 20 minutes post-injection. The ENB system allowed accurate ICG injection surrounding the pseudo-tumors., Conclusions: ENB-guided ICG injection followed by NIR thoracoscopy was technically feasible for SN mapping in the porcine lung. This promising platform may be translated into human clinical trials and is suited for MIS.
- Published
- 2015
- Full Text
- View/download PDF
27. Whole-body organ-level and kidney micro-dosimetric evaluations of (64)Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin ((64)Cu-MM-302) in rodents and primates.
- Author
-
Gaddy DF, Lee H, Zheng J, Jaffray DA, Wickham TJ, and Hendriks BS
- Abstract
Background: Features of the tumor microenvironment influence the efficacy of cancer nanotherapeutics. The ability to directly radiolabel nanotherapeutics offers a valuable translational tool to obtain biodistribution and tumor deposition data, testing the hypothesis that the extent of delivery predicts therapeutic outcome. In support of a first in-human clinical trial with (64)Cu-labeled HER2-targeted liposomal doxorubicin ((64)Cu-MM-302), a preclinical dosimetric analysis was performed., Methods: Whole-body biodistribution and pharmacokinetic data were obtained in mice that received (64)Cu-MM-302 and used to estimate absorbed radiation doses in normal human organs. PET/CT imaging revealed non-uniform distribution of (64)Cu signal in mouse kidneys. Kidney micro-dosimetry analysis was performed in mice and squirrel monkeys, using a physiologically based pharmacokinetic model to estimate the full dynamics of the (64)Cu signal in monkeys., Results: Organ-level dosimetric analysis of mice receiving (64)Cu-MM-302 indicated that the heart was the organ receiving the highest radiation absorbed dose, due to extended liposomal circulation. However, PET/CT imaging indicated that (64)Cu-MM-302 administration resulted in heterogeneous exposure in the kidney, with a focus of (64)Cu activity in the renal pelvis. This result was reproduced in primates. Kidney micro-dosimetry analysis illustrated that the renal pelvis was the maximum exposed tissue in mice and squirrel monkeys, due to the highly concentrated signal within the small renal pelvis surface area., Conclusions: This study was used to select a starting clinical radiation dose of (64)Cu-MM-302 for PET/CT in patients with advanced HER2-positive breast cancer. Organ-level dosimetry and kidney micro-dosimetry results predicted that a radiation dose of 400 MBq of (64)Cu-MM-302 should be acceptable in patients.
- Published
- 2015
- Full Text
- View/download PDF
28. Noise distribution and denoising of current density images.
- Author
-
Beheshti M, Foomany FH, Magtibay K, Jaffray DA, Krishnan S, Nanthakumar K, and Umapathy K
- Abstract
Current density imaging (CDI) is a magnetic resonance (MR) imaging technique that could be used to study current pathways inside the tissue. The current distribution is measured indirectly as phase changes. The inherent noise in the MR imaging technique degrades the accuracy of phase measurements leading to imprecise current variations. The outcome can be affected significantly, especially at a low signal-to-noise ratio (SNR). We have shown the residual noise distribution of the phase to be Gaussian-like and the noise in CDI images approximated as a Gaussian. This finding matches experimental results. We further investigated this finding by performing comparative analysis with denoising techniques, using two CDI datasets with two different currents (20 and 45 mA). We found that the block-matching and three-dimensional (BM3D) technique outperforms other techniques when applied on current density ([Formula: see text]). The minimum gain in noise power by BM3D applied to [Formula: see text] compared with the next best technique in the analysis was found to be around 2 dB per pixel. We characterize the noise profile in CDI images and provide insights on the performance of different denoising techniques when applied at two different stages of current density reconstruction.
- Published
- 2015
- Full Text
- View/download PDF
29. A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors.
- Author
-
Stapleton S, Milosevic M, Allen C, Zheng J, Dunne M, Yeung I, and Jaffray DA
- Subjects
- Biological Transport, Humans, Permeability, Liposomes pharmacokinetics, Liposomes pharmacology, Models, Biological, Neoplasms drug therapy, Neoplasms metabolism, Tumor Microenvironment
- Abstract
The discovery of the enhanced permeability and retention (EPR) effect has resulted in the development of nanomedicines, including liposome-based formulations of drugs, as cancer therapies. The use of liposomes has resulted in substantial increases in accumulation of drugs in solid tumors; yet, significant improvements in therapeutic efficacy have yet to be achieved. Imaging of the tumor accumulation of liposomes has revealed that this poor or variable performance is in part due to heterogeneous inter-subject and intra-tumoral liposome accumulation, which occurs as a result of an abnormal transport microenvironment. A mathematical model that relates liposome accumulation to the underlying transport properties in solid tumors could provide insight into inter and intra-tumoral variations in the EPR effect. In this paper, we present a theoretical framework to describe liposome transport in solid tumors. The mathematical model is based on biophysical transport equations that describe pressure driven fluid flow across blood vessels and through the tumor interstitium. The model was validated by direct comparison with computed tomography measurements of tumor accumulation of liposomes in three preclinical tumor models. The mathematical model was fit to liposome accumulation curves producing predictions of transport parameters that reflect the tumor microenvironment. Notably, all fits had a high coefficient of determination and predictions of interstitial fluid pressure agreed with previously published independent measurements made in the same tumor type. Furthermore, it was demonstrated that the model attributed inter-subject heterogeneity in liposome accumulation to variations in peak interstitial fluid pressure. These findings highlight the relationship between transvascular and interstitial flow dynamics and variations in the EPR effect. In conclusion, we have presented a theoretical framework that predicts inter-subject and intra-tumoral variations in the EPR effect based on fundamental properties of the tumor microenvironment and forms the basis for transport modeling of liposome drug delivery.
- Published
- 2013
- Full Text
- View/download PDF
30. Comparison of computed tomography- and optical image-based assessment of liposome distribution.
- Author
-
Huang H, Dunne M, Lo J, Jaffray DA, and Allen C
- Subjects
- Animals, Cell Line, Tumor, Female, Humans, Imaging, Three-Dimensional, Iohexol, Liposomes administration & dosage, Lung Neoplasms metabolism, Mice, Liposomes metabolism, Optical Imaging methods, Tomography, X-Ray Computed methods
- Abstract
The use of multimodal imaging as a tool to assess the in vivo pharmacokinetics and biodistribution of nanocarriers is important in understanding the nature of their in vivo transport. The current study reports the development of a nano-sized liposomal computed tomographic (CT)/optical imaging probe carrying iohexol and Cy5.5 and its use in micro-CT and optical imaging to quantitatively assess the whole-body (macroscopic), intratumoral, and microscopic distribution over a period of 8 days. These multimodal liposomes have a vascular half-life of 30.3 ± 8.9 hours in mice bearing subcutaneous H520 non-small cell lung cancer tumors, with the maximum liposome accumulation in tumor achieved 48 hours postinjection. The in vivo liposome distribution and stability were quantitatively assessed using both micro-CT and fluorescence molecular tomography. The combination of CT and optical imaging enables visualization of the liposomes at the whole-body, tumor, and cellular scales with high sensitivity. Such noninvasive tracking of therapeutic vehicles at the macro- and microscale is important for informed and rational development of novel nanocarrier systems.
- Published
- 2013
31. Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers.
- Author
-
Luo T, Yu J, Nguyen J, Wang CR, Bristow RG, Jaffray DA, Zhou XZ, Lu KP, and Lu QB
- Subjects
- Apoptosis, Cell Line, Tumor, Cisplatin administration & dosage, DNA Damage, Electron Transport, Female, Flow Cytometry, Humans, Lung Neoplasms pathology, Ovarian Neoplasms pathology, Spectrometry, Fluorescence, Tetramethylphenylenediamine administration & dosage, Uterine Cervical Neoplasms pathology, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lung Neoplasms drug therapy, Ovarian Neoplasms drug therapy, Uterine Cervical Neoplasms drug therapy
- Abstract
The platinum-based chemotherapy is the standard treatment for several types of cancer. However, cancer cells often become refractory with time and most patients with serious cancers die of drug resistance. Recently, we have discovered a unique dissociative electron-transfer mechanism of action of cisplatin, the first and most widely used platinum-based anticancer drug. Here, we show that the combination of cisplatin with an exemplary biological electron donor, N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD), may overcome the resistance of cancer cells to cisplatin. Our steady-state absorption and fluorescence spectroscopic measurements confirm the effective dissociative electron-transfer reaction between TMPD and cisplatin. More significantly, we found that the combination of 100 μM TMPD with cisplatin enhances double-strand breaks of plasmid DNA by a factor of approximately 3.5 and dramatically reduces the viability of cisplatin-sensitive human cervical (HeLa) cancer cells and highly cisplatin-resistant human ovarian (NIH:OVCAR-3) and lung (A549) cancer cells. Furthermore, this combination enhances apoptosis and DNA fragmentation by factors of 2-5 compared with cisplatin alone. These results demonstrate that this combination treatment not only results in a strong synergetic effect, but also makes resistant cancer cells sensitive to cisplatin. Because cisplatin is the cornerstone agent for the treatment of a variety of human cancers (including testicular, ovarian, cervical, bladder, head/neck, and lung cancers), our results show both the potential to improve platinum-based chemotherapy of various human cancers and the promise of femtomedicine as an emerging frontier in advancing cancer therapy.
- Published
- 2012
- Full Text
- View/download PDF
32. Simultaneous nonrigid registration, segmentation, and tumor detection in MRI guided cervical cancer radiation therapy.
- Author
-
Lu C, Chelikani S, Jaffray DA, Milosevic MF, Staib LH, and Duncan JS
- Subjects
- Female, Humans, Image Enhancement methods, Image Interpretation, Computer-Assisted methods, Imaging, Three-Dimensional methods, Radiotherapy, Conformal methods, Reproducibility of Results, Sensitivity and Specificity, Algorithms, Magnetic Resonance Imaging methods, Pattern Recognition, Automated methods, Radiotherapy, Image-Guided methods, Subtraction Technique, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms radiotherapy
- Abstract
External beam radiation therapy (EBRT) for the treatment of cancer enables accurate placement of radiation dose on the cancerous region. However, the deformation of soft tissue during the course of treatment, such as in cervical cancer, presents significant challenges for the delineation of the target volume and other structures of interest. Furthermore, the presence and regression of pathologies such as tumors may violate registration constraints and cause registration errors. In this paper, automatic segmentation, nonrigid registration and tumor detection in cervical magnetic resonance (MR) data are addressed simultaneously using a unified Bayesian framework. The proposed novel method can generate a tumor probability map while progressively identifying the boundary of an organ of interest based on the achieved nonrigid transformation. The method is able to handle the challenges of significant tumor regression and its effect on surrounding tissues. The new method was compared to various currently existing algorithms on a set of 36 MR data from six patients, each patient has six T2-weighted MR cervical images. The results show that the proposed approach achieves an accuracy comparable to manual segmentation and it significantly outperforms the existing registration algorithms. In addition, the tumor detection result generated by the proposed method has a high agreement with manual delineation by a qualified clinician.
- Published
- 2012
- Full Text
- View/download PDF
33. In vivo optical imaging of tumor and microvascular response to ionizing radiation.
- Author
-
Maeda A, Leung MK, Conroy L, Chen Y, Bu J, Lindsay PE, Mintzberg S, Virtanen C, Tsao J, Winegarden NA, Wang Y, Morikawa L, Vitkin IA, Jaffray DA, Hill RP, and DaCosta RS
- Subjects
- Animals, Cell Line, Tumor, Female, Humans, Mice, Microvessels metabolism, Microvessels physiopathology, Neovascularization, Pathologic, Optical Imaging instrumentation, Radiobiology instrumentation, Thrombosis complications, Time Factors, Tomography, Optical Coherence, Transcriptome radiation effects, Uterine Cervical Neoplasms complications, Uterine Cervical Neoplasms genetics, Uterine Cervical Neoplasms pathology, X-Rays, Microvessels radiation effects, Optical Imaging methods, Radiobiology methods, Uterine Cervical Neoplasms blood supply
- Abstract
Radiotherapy is a widely used cancer treatment. However, understanding how ionizing radiation affects tumor cells and their vasculature, particularly at cellular, subcellular, genetic, and protein levels, has been limited by an inability to visualize the response of these interdependent components within solid tumors over time and in vivo. Here we describe a new preclinical experimental platform combining intravital multimodal optical microscopy for cellular-level longitudinal imaging, a small animal x-ray microirradiator for reproducible spatially-localized millimeter-scale irradiations, and laser-capture microdissection of ex vivo tissues for transcriptomic profiling. Using this platform, we have developed new methods that exploit the power of optically-enabled microscopic imaging techniques to reveal the important role of the tumor microvasculature in radiation response of tumors. Furthermore, we demonstrate the potential of this preclinical platform to study quantitatively--with cellular and sub-cellular details--the spatio-temporal dynamics of the biological response of solid tumors to ionizing radiation in vivo.
- Published
- 2012
- Full Text
- View/download PDF
34. Direct observation of ultrafast-electron-transfer reactions unravels high effectiveness of reductive DNA damage.
- Author
-
Nguyen J, Ma Y, Luo T, Bristow RG, Jaffray DA, and Lu QB
- Subjects
- Biophysics, Electrophoresis, Agar Gel, Free Radical Scavengers metabolism, Hydroxides metabolism, Oxidation-Reduction, Spectrum Analysis, Water metabolism, DNA Damage physiology, Electron Transport physiology, Hydroxides chemistry, Water chemistry
- Abstract
Both water and electron-transfer reactions play important roles in chemistry, physics, biology, and the environment. Oxidative DNA damage is a well-known mechanism, whereas the relative role of reductive DNA damage is unknown. The prehydrated electron (e(pre)-), a novel species of electrons in water, is a fascinating species due to its fundamental importance in chemistry, biology, and the environment. e(pre)- is an ideal agent to observe reductive DNA damage. Here, we report both the first in situ femtosecond time-resolved laser spectroscopy measurements of ultrafast-electron-transfer (UET) reactions of e(pre)- with various scavengers (KNO(3), isopropanol, and dimethyl sulfoxide) and the first gel electrophoresis measurements of DNA strand breaks induced by e(pre)- and OH(•) radicals co-produced by two-UV-photon photolysis of water. We strikingly found that the yield of reductive DNA strand breaks induced by each e(pre)- is twice the yield of oxidative DNA strand breaks induced by each OH(•) radical. Our results not only unravel the long-standing mystery about the relative role of radicals in inducing DNA damage under ionizing radiation, but also challenge the conventional notion that oxidative damage is the main pathway for DNA damage. The results also show the potential of femtomedicine as a new transdisciplinary frontier and the broad significance of UET reactions of e(pre)- in many processes in chemistry, physics, biology, and the environment.
- Published
- 2011
- Full Text
- View/download PDF
35. Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.
- Author
-
Walia JS, Neschadim A, Lopez-Perez O, Alayoubi A, Fan X, Carpentier S, Madden M, Lee CJ, Cheung F, Jaffray DA, Levade T, McCart JA, and Medin JA
- Subjects
- Animals, Genetic Vectors, Hematopoietic Stem Cells physiology, Lentivirus, Macaca mulatta, Male, Transduction, Genetic, Transplantation, Autologous, Acid Ceramidase genetics, Farber Lipogranulomatosis therapy, Genetic Therapy methods, Hematopoietic Stem Cell Transplantation methods
- Abstract
Farber disease is a rare lysosomal storage disorder (LSD) that manifests due to acid ceramidase (AC) deficiencies and ceramide accumulation. We present a preclinical gene therapy study for Farber disease employing a lentiviral vector (LV-huAC/huCD25) in three enzymatically normal nonhuman primates. Autologous, mobilized peripheral blood (PB) cells were transduced and infused into fully myelo-ablated recipients with tracking for at least 1 year. Outcomes were assessed by measuring the AC specific activity, ceramide levels, vector persistence/integration, and safety parameters. We observed no hematological, biochemical, radiological, or pathological abnormalities. Hematological recovery occurred by approximately 3 weeks. Vector persistence was observed in PB and bone marrow (BM) cells by qualitative and quantitative PCR. We did not observe any clonal proliferation of PB and BM cells. Importantly, AC-specific activity was detected above normal levels in PB and BM cells analyzed post-transplantation and in spleens and livers at the endpoint of the study. Decreases of ceramide in PB cells as well as in spleen and liver tissues were seen. We expect that this study will provide a roadmap for implementation of clinical gene therapy protocols targeting hematopoietic cells for Farber disease and other LSDs.
- Published
- 2011
- Full Text
- View/download PDF
36. Gold nanoparticles as radiation sensitizers in cancer therapy.
- Author
-
Chithrani DB, Jelveh S, Jalali F, van Prooijen M, Allen C, Bristow RG, Hill RP, and Jaffray DA
- Subjects
- Active Transport, Cell Nucleus, Cell Nucleus metabolism, DNA Breaks, Double-Stranded drug effects, DNA Breaks, Double-Stranded radiation effects, Dose-Response Relationship, Drug, Feasibility Studies, Gold metabolism, HeLa Cells, Histones metabolism, Humans, Intracellular Signaling Peptides and Proteins metabolism, Neoplasms metabolism, Neoplasms pathology, Particle Size, Radiation Dosage, Radiation-Sensitizing Agents metabolism, Tumor Suppressor p53-Binding Protein 1, X-Ray Therapy, Gold chemistry, Gold pharmacology, Metal Nanoparticles, Neoplasms radiotherapy, Radiation-Sensitizing Agents chemistry, Radiation-Sensitizing Agents pharmacology
- Abstract
Among other nanoparticle systems, gold nanoparticles have been explored as radiosensitizers. While most of the research in this area has focused on either gold nanoparticles with diameters of less than 2 nm or particles with micrometer dimensions, it has been shown that nanoparticles 50 nm in diameter have the highest cellular uptake. We present the results of in vitro studies that focus on the radiosensitization properties of nanoparticles in the size range from 14-74 nm. Radiosensitization was dependent on the number of gold nanoparticles internalized within the cells. Gold nanoparticles 50-nm in diameter showed the highest radiosensitization enhancement factor (REF) (1.43 at 220 kVp) compared to gold nanoparticles of 14 and 74 nm (1.20 and 1.26, respectively). Using 50-nm gold nanoparticles, the REF for lower- (105 kVp) and higher- (6 MVp) energy photons was 1.66 and 1.17, respectively. DNA double-strand breaks were quantified using radiation-induced foci of gamma-H2AX and 53BP1, and a modest increase in the number of foci per nucleus was observed in irradiated cell populations with internalized gold nanoparticles. The outcome of this research will enable the optimization of gold nanoparticle-based sensitizers for use in therapy.
- Published
- 2010
- Full Text
- View/download PDF
37. Accuracy of automatic couch corrections with on-line volumetric imaging.
- Author
-
Li W, Moseley DJ, Manfredi T, and Jaffray DA
- Subjects
- Diagnostic Imaging, Humans, Neoplasms radiotherapy, Phantoms, Imaging, Radiotherapy Planning, Computer-Assisted, Cone-Beam Computed Tomography instrumentation, Cone-Beam Computed Tomography methods, Neoplasms diagnostic imaging, Patient Positioning
- Abstract
The purpose of this study was to characterize automatic remote couch adjustment and to assess the accuracy of automatic couch corrections following localization with cone-beam CT (CBCT). Automatic couch movement was evaluated through passive reflector markers placed on a phantom, tracked with an optical tracking system (OTS). Repeated couch movements in the lateral, cranial/caudal, and vertical directions were monitored through the OTS to assess velocity and response time. In conjunction with CBCT, remote table movement for patient displacements following initial setup was available on four linear accelerators (Elekta Synergy). After the initial CBCT scan assessment, patients with isocenter displacements that exceeded clinical protocol tolerances were corrected using remote automatic couch movement. A verification CBCT scan was acquired after any remote movements. These verification CBCT datasets were assessed for the following time periods: one month post clinical installation, and six months later to monitor remote couch correction stability. Residual error analysis was evaluated using the verification scans. The mean +/- standard deviations (mu +/- sigma) of couch movement based on phantom measurements with the OTS were 0.16 +/- 0.48 mm, 0.32 +/- 0.30 mm, 0.11 +/- 0.12 mm in the L/R, A/P, and S/I couch directions, respectively. The fastest maximum velocity was observed in the inferior direction at 10.5 mm/s, and the slowest maximum velocity in the left direction at 3.6 mm/s. From 1134 verification CBCT registrations for 207 patients, the residual error for each translational direction from each month evaluated are reported. The mu was less than 0.3 mm in all directions, and sigma was in the order of 1 mm. At a 3 mm threshold, 21 of the 1134 fractions (2%) exceeded tolerance, attributed to patient intrafraction movement. Remote automatic couch movement is reliable and effective for adjusting patient position with a precision of approximately 1mm. Patient residual error observed in this study demonstrates that displacement is minimal after remote couch adjustment.
- Published
- 2009
- Full Text
- View/download PDF
38. Intraoperative cone-beam CT for image-guided tibial plateau fracture reduction.
- Author
-
Khoury A, Siewerdsen JH, Whyne CM, Daly MJ, Kreder HJ, Moseley DJ, and Jaffray DA
- Subjects
- Aged, 80 and over, Cadaver, Equipment Design, Humans, Tibial Fractures diagnostic imaging, Cone-Beam Computed Tomography instrumentation, Fracture Fixation methods, Monitoring, Intraoperative methods, Surgery, Computer-Assisted methods, Tibial Fractures surgery
- Abstract
Objectives: A mobile isocentric C-arm was modified in our laboratory in collaboration with Siemens Medical Solutions to include a large-area flat-panel detector providing multi-mode fluoroscopy and cone-beam CT (CBCT) imaging. This technology is an important advance over existing intraoperative imaging (e.g., Iso-C(3D)), offering superior image quality, increased field of view, higher spatial resolution, and soft-tissue visibility. The aim of this study was to assess the system's performance and image quality in tibial plateau (TP) fracture reconstruction., Methods: Three TP fractures were simulated in fresh-frozen cadaveric knees through combined axial loading and lateral impact. The fractures were reduced through a lateral approach and assessed by fluoroscopy. The reconstruction was then assessed using CBCT. If necessary, further reduction and localization of remaining displaced bone fragments was performed using CBCT images for guidance. CBCT image quality was assessed with respect to projection speed, dose and filtering technique., Results: CBCT imaging provided exquisite visualization of articular details, subtle fragment detection and localization, and confirmation of reduction and implant placement. After fluoroscopic images indicated successful initial reduction, CBCT imaging revealed areas of malalignment and displaced fragments. CBCT facilitated fragment localization and improved anatomic reduction. CBCT image noise increased gradually with reduced dose, but little difference in images resulted from increased projections. High-resolution reconstruction provided better delineation of plateau depressions., Conclusion: This study demonstrated a clear advantage of intraoperative CBCT over 2D fluoroscopy and Iso-C(3D) in TP fracture fixation. CBCT imaging provided benefits in fracture type diagnosis, localization of fracture fragments, and intraoperative 3D confirmation of anatomic reduction.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.